GlassScriptPhysician profile
Bryan Scott Engel
NPI 1013262518
$2,415.52
in general payments reported to CMS, 2019-2025
23 companies · $818 in 2025
The $818 reported for 2025 was more than what 82% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $314 · 2022: $452 · 2023: $642 · 2024: $189 · 2025: $818.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,360 · Travel and Lodging: $289.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,360.03 |
| Travel and Lodging | $289.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Curonix LLC | $488.62 | 2023 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Boston Scientific Corporation | $457.57 | 2022-2025 | Wavewriter Alpha Prime 16, General - Pain Management |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $447.32 | 2021-2025 | Relistor |
| Grt US Holding, INC. | $196.86 | 2021-2022 | |
| Forte Bio-Pharma LLC | $117.36 | 2021-2025 | Prolate, Tanlor, Nalocet |
| Vertex Pharmaceuticals Incorporated | $110.33 | 2025 | |
| Spr Therapeutics, INC | $91.15 | 2023-2024 | Sprint Pns System |
| Biotronik Nro, INC. | $79.53 | 2024-2025 | Prospera |
| Valinor Pharma, LLC | $68.85 | 2025 | Movantik |
| Abbott Laboratories | $59.94 | 2025 | Eterna |
| Averitas Pharma INC. | $51.12 | 2023-2025 | Qutenza |
| Collegium Pharmaceutical, INC. | $46.57 | 2021-2022 | |
| Protega Pharmaceutials INC | $30.64 | 2022-2024 | Roxybond |
| Arbor Pharmaceuticals, INC. | $24.39 | 2021 | |
| Redhill Biopharma INC. | $19.69 | 2021 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $18.48 | 2023 | Senza |
| Masimo Corporation | $18.33 | 2023 | Patient Safetynet System |
| Spinal Simplicity, LLC | $18.06 | 2023 | Ha Minuteman G3-R |
| Azurity Pharmaceuticals, INC. | $17.80 | 2023 | Horizant |
| Pacira Pharmaceuticals Incorporated | $15.78 | 2025 | Iovera, Zilretta |
| Scilex Pharmaceuticals INC. | $14.50 | 2024 | |
| Radius Health, INC. | $11.41 | 2021 | |
| Mml US, INC. | $11.22 | 2025 | Reactiv8 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bryan Engel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.